These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34991042)

  • 1. Neurocognition, functional outcome, and quality of life in remitted and non-remitted schizophrenia: A comparison with euthymic bipolar I disorder and a control group.
    Jiménez-López E; Villanueva-Romero CM; Sánchez-Morla EM; Martínez-Vizcaíno V; Ortiz M; Rodriguez-Jimenez R; Vieta E; Santos JL
    Schizophr Res; 2022 Feb; 240():81-91. PubMed ID: 34991042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive Impairments (NCI) in bipolar disorder: Comparison with schizophrenia and healthy controls.
    Esan O; Oladele O; Adediran KI; Abiona TO
    J Affect Disord; 2020 Dec; 277():175-181. PubMed ID: 32829193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross diagnostic comparisons of quality of life deficits in remitted and unremitted patients with schizophrenia and bipolar disorder.
    Sum MY; Ho NF; Sim K
    Schizophr Res; 2015 Oct; 168(1-2):191-6. PubMed ID: 26341581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up.
    Jiménez-López E; Sánchez-Morla EM; López-Villarreal A; Aparicio AI; Martínez-Vizcaíno V; Vieta E; Rodriguez-Jimenez R; Santos JL
    Eur Psychiatry; 2019 Feb; 56():60-68. PubMed ID: 30500572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS-J).
    Terachi S; Yamada T; Pu S; Yokoyama K; Matsumura H; Kaneko K
    Psychiatry Res; 2017 Aug; 254():205-210. PubMed ID: 28476012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of neurocognition on mentalizing in euthymic bipolar disorder versus schizophrenia.
    Konstantakopoulos G; Ioannidi N; Psarros C; Patrikelis P; Stefanatou P; Kravariti E
    Cogn Neuropsychiatry; 2020 Nov; 25(6):405-420. PubMed ID: 33050828
    [No Abstract]   [Full Text] [Related]  

  • 14. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A; Penadés R; Vieta E; Colom F; Reinares M; Benabarre A; Salamero M; Gastó C
    Psychother Psychosom; 2002; 71(1):39-46. PubMed ID: 11740167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.
    Depp CA; Moore DJ; Sitzer D; Palmer BW; Eyler LT; Roesch S; Lebowitz BD; Jeste DV
    J Affect Disord; 2007 Aug; 101(1-3):201-9. PubMed ID: 17224185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar social cognition signatures in remitted schizophrenia and bipolar disorder.
    Mehta UM; Punith M; Kumar CN; Kumar JK; Reddy YJ; Thirthalli J
    Asian J Psychiatr; 2021 Mar; 57():102593. PubMed ID: 33581371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
    Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
    J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder.
    Vaskinn A; Sundet K; Simonsen C; Hellvin T; Melle I; Andreassen OA
    Neuropsychology; 2011 Jul; 25(4):499-510. PubMed ID: 21463042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.